Biomaterials Forum Issues
Publications
2024 Q4 Biomaterials Forum is Available Now!
This issue includes a highlight of the celebration of the 50-year legacy of the Society at the 2025 Annual Meeting, as well as details of the recent US FDA approval of two new medical therapies, and the US DOJ's efforts to block UnitedHealth Group's proposed acquisition of Amedisys. Read more inside!
Fourth Quarter 2019
Third Quarter 2019
Second Quarter 2019
First Quarter 2019
Fourth Quarter 2018
Third Quarter 2018
Second Quarter 2018
First Quarter 2018
Fourth Quarter 2017
Third Quarter 2017
Second Quarter 2017
First Quarter 2017
Fourth Quarter 2016
Third Quarter 2016
Second Quarter 2016
First Quarter 2016
Fourth Quarter 2015
Third Quarter 2015
Second Quarter 2015
First Quarter 2015